temozolomide has been researched along with deoxyguanosine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bocangel, DB; Kokkinakis, DM; Moschel, RC; Pegg, AE; Schold, SC | 1 |
| Hall, CN; Harrison, KL; Lees, NP; Margison, GP; Povey, AC; Wood, M | 1 |
| Gerson, SL; Liu, L; Nakatsuru, Y | 1 |
| Ahmed, MM; Chendil, D; Kokkinakis, DM; Moschel, RC; Pegg, AE | 1 |
| Fairbairn, LJ; Humphries, RK; Margison, GP; Milsom, MD; Woolford, LB | 1 |
| Abdel-Wahab, OI; Abdel-Wahab, Z; Augustine, C; Cheng, TY; Friedman, HS; Grubbs, E; Ko, SH; Pruitt, SK; Tyler, DS; Ueno, T; Yoshimoto, Y | 1 |
| Adema, AD; Honeywell, RJ; Peters, GJ; van der Born, K | 1 |
7 other study(ies) available for temozolomide and deoxyguanosine
| Article | Year |
|---|---|
Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carmustine; Dacarbazine; Deoxyguanosine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glioma; Guanine; Humans; Mice; Mice, Nude; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Transplantation, Heterologous; Tumor Cells, Cultured | 2001 |
Development and application of a sensitive and rapid immunoassay for the quantitation of N7-methyldeoxyguanosine in DNA samples.
Topics: Animals; Antineoplastic Agents, Alkylating; Biomarkers; Brain; Dacarbazine; Deoxyguanosine; DNA Adducts; DNA Methylation; Immunoassay; Liver; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Wistar; Sensitivity and Specificity; Temozolomide; Thymus Gland | 2001 |
Base excision repair as a therapeutic target in colon cancer.
Topics: Animals; Antineoplastic Agents, Alkylating; Base Pair Mismatch; Bone Marrow Diseases; Chromosome Aberrations; Colonic Neoplasms; Dacarbazine; Deoxyguanosine; DNA Adducts; DNA Repair; DNA, Neoplasm; Drug Synergism; Enzyme Inhibitors; Female; Humans; Hydroxylamines; Mice; Mice, Nude; O(6)-Methylguanine-DNA Methyltransferase; Sister Chromatid Exchange; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
Topics: Alkylating Agents; Animals; Antineoplastic Agents, Alkylating; Carmustine; Cell Line, Tumor; Dacarbazine; Deoxyguanosine; DNA Repair; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanine; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; O(6)-Methylguanine-DNA Methyltransferase; Pancreatic Neoplasms; Temozolomide; Time Factors | 2003 |
Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4.
Topics: Animals; Bone Marrow Cells; Cell Line; Colony-Forming Units Assay; Dacarbazine; Deoxyguanosine; Genetic Vectors; Green Fluorescent Proteins; Hematopoietic Stem Cell Transplantation; Homeodomain Proteins; Mice; Mutation; O(6)-Methylguanine-DNA Methyltransferase; Retroviridae; Temozolomide; Transcription Factors | 2004 |
Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dacarbazine; Deoxyguanosine; Drug Resistance, Neoplasm; Humans; Injections, Intra-Arterial; Melanoma; O(6)-Methylguanine-DNA Methyltransferase; Rats; Rats, Inbred Strains; Skin Neoplasms; Temozolomide; Xenograft Model Antitumor Assays | 2006 |
Cell cycle effects and increased adduct formation by temozolomide enhance the effect of cytotoxic and targeted agents in lung cancer cell lines.
Topics: Animals; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Dacarbazine; Deoxycytidine; Deoxyguanosine; DNA Adducts; DNA Methylation; Drug Synergism; Gemcitabine; Humans; Lung Neoplasms; Mice; O(6)-Methylguanine-DNA Methyltransferase; Paclitaxel; Piperidines; Pyridines; Temozolomide | 2009 |